Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ODC1 | P11926 | 1/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.31 |
| ▸ | CA1 | P00915 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 2/20 | 0.31 |
| ▸ | CA3 | P07451 | 2/20 | 0.31 |
| ▸ | CA4 | P22748 | 2/20 | 0.31 |
| ▸ | CA6 | P23280 | 2/20 | 0.31 |
| ▸ | CA5A | P35218 | 2/20 | 0.31 |
| ▸ | CA7 | P43166 | 2/20 | 0.31 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.31 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12918856 | 1.00 | ODC1 (0.37) | ODC1NFKB1CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL23202615 | 0.96 | ODC1 (0.35) | ODC1NFKB1 | |
| SCHEMBL6051828 | 0.93 | ODC1 (0.47) | ODC1NFKB1CA12CA1CA2 | |
| SCHEMBL4001682 | 0.92 | ODC1 (0.37) | ODC1NFKB1CA12CA1CA2 | |
| SCHEMBL30050208 | 0.90 | ODC1 (0.38) | ODC1 | |
| SCHEMBL17110675 | 0.90 | ODC1 (0.45) | ODC1NFKB1CA12CA1CA2 | |
| SCHEMBL3996449 | 0.89 | CA1 (0.38) | ODC1NFKB1CA12CA1CA2 | |
| SCHEMBL18902842 | 0.89 | CA1 (0.38) | ODC1NFKB1CA12CA1CA2 | |
| SCHEMBL3998325 | 0.89 | CA1 (0.38) | ODC1NFKB1CA12CA1CA2 | |
| SCHEMBL16353341 | 0.89 | MEN1 (0.36) | ODC1NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12479840-B2 | HMG-CoA reductase degradation inducing compound | UPPTHERA INC. (KR) | 2025-11-25 | — | — | US | disclosed |
| US-20250325673-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2025-10-23 | — | — | US | disclosed |
| EP-4613773-A2 | IRAK DEGRADERS AND USES THEREOF | Kymera Therapeutics, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| EP-3731869-B1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS INC (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | SYMRISE AG (DE) | 2025-05-22 | — | — | US | disclosed |
| CN-119569587-A | Preparation method of alkoxy diethyl amine | 上海彩迩文生化科技有限公司 | 2025-03-07 | — | — | CN | disclosed |
| EP-3663366-B1 | USE OF PHYSIOLOGICAL COOLING INGREDIENTS AND AGENTS CONTAINING SUCH ACTIVE INGREDIENTS | SYMRISE AG (DE) | 2025-01-08 | — | — | EP | disclosed |
| US-20250000985-A1 | IRAK DEGRADERS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2025-01-02 | — | — | US | disclosed |
| US-12168057-B2 | IRAK degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2024-12-17 | — | — | US | disclosed |
| EP-4469439-A1 | NEW COOLANTS, AND PREPARATIONS CONTAINING SAME | Symrise AG (DE) | 2024-12-04 | — | — | EP | disclosed |
| EP-1200507-B1 | ZWITTERIONIC POLYETHERPOLYAMINES AND A PROCESS FOR THEIR PRODUCTION | BASF AG (DE) | 2003-11-19 | — | — | EP | disclosed |
| US-20020165111-A1 | LAUNDRY DETERGENT COMPOSITIONS COMPRISING ZWITTERIONIC POLYAMINES AND XYLOGLUCANASE | PROCTER & GAMBLE COMPANY, THE | 2002-11-07 | — | — | US | disclosed |
| US-6472359-B1 | Laundry detergent compositions comprising zwitterionic polyamines and xyloglucanase | THE PROCTER & GAMBLE COMPANY | 2002-10-29 | — | — | US | disclosed |
| EP-1200507-A1 | ZWITTERIONIC POLYETHERPOLYAMINES AND A PROCESS FOR THEIR PRODUCTION | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-02 | — | — | EP | disclosed |
| EP-1196525-A1 | LAUNDRY DETERGENT COMPOSITIONS COMPRISING POLYAMINES AND MID-CHAIN BRANCHED SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2002-04-17 | — | — | EP | disclosed |
| EP-1196524-A1 | LAUNDRY DETERGENT COMPOSITIONS COMPRISING ZWITTERIONIC POLYAMINES AND MID-CHAIN BRANCHED SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2002-04-17 | — | — | EP | disclosed |
| WO-2001005872-A1 | ZWITTERIONIC POLYETHERPOLYAMINES AND A PROCESS FOR THEIR PRODUCTION | BASF AKTIENGESELLSCHAFT (DE) | 2001-01-25 | — | — | WO | disclosed |
| WO-2001005923-A1 | LAUNDRY DETERGENT COMPOSITIONS COMPRISING ZWITTERIONIC POLYAMINES AND MID-CHAIN BRANCHED SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-25 | — | — | WO | disclosed |
| WO-2001005924-A1 | LAUNDRY DETERGENT COMPOSITIONS COMPRISING POLYAMINES AND MID-CHAIN BRANCHED SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2001-01-25 | — | — | WO | disclosed |
| EP-0393549-A2 | Process for preparing linear polyamids containing ether linkages in their polymeric chain | BASF Aktiengesellschaft (DE) | 1990-10-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325673-A1 | IRAK DEGRADERS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | ODC1 3109/4885NFKB1 126/4885CA12 4583/4885 |
| US-20250000985-A1 | IRAK DEGRADERS AND USES THEREOF | IRAK2, IRAK3, IRAK1 | ODC1 3109/4885NFKB1 126/4885CA12 4583/4885 |
| US-12168057-B2 | IRAK degraders and uses thereof | IRAK2, IRAK3, IRAK1 | ODC1 3109/4885NFKB1 126/4885CA12 4583/4885 |
| US-20250163006-A1 | New Coolants, and Preparations Containing Same | TTR, TAS2R5, TAS2R50 | ODC1 3461/4885NFKB1 3887/4885CA12 744/4885 |
| US-12479840-B2 | HMG-CoA reductase degradation inducing compound | HMGCR, HMGB2, LDLR | ODC1 2645/4885NFKB1 677/4885CA12 4432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.